Objectives: Ultrasound-guided access for percutaneous endovascular aortic procedures has been increasingly used. We developed a prediction model to risk stratify patients for access site complications following ultrasound-guided percutaneous approach.
Methods: We performed a retrospective institutional review of consecutive patients who underwent percutaneous endovascular repair of emergent and elective aortic pathology, from 2014 to 2016. We excluded patients undergoing initial femoral artery (FA) cutdown, endoleak treatment, or aortic arch reconstruction. Our primary outcome was groin access site complication, which included bleeding, thrombosis, infection, and conversion to femoral cutdown. We created a 15-point risk model for groin access complication using logistic regression.
Results: We identified 292 FAs from 152 patients undergoing endovascular aortic repair procedures (endovascular aortic aneurysm repair 76.8%, fenestrated endovascular aortic aneurysm repair 7.7%, thoracic endovascular aortic aneurysm repair 15.5%). Surgeons used percutaneous access in 97.3% of FAs (2.7% underwent planned femoral endarterectomy), with 100% ultrasound use and 100% initial success rate. Superficial .0-84.5; P ¼ .001), FA stenosis of >50% (OR, 52.1; 95% CI, 7.7-351.5; P # . 001), FA stenosis of >75% (OR, 271.5; 95% CI, 15.1-4888.6; P # .001), and postoperative anticoagulation (OR, 10.5; 95% CI, 2.0-54.0; P ¼ .005). A risk prediction model based on these criteria produced a C statistic of .91, a Hosmer-Lemeshow goodness of fit of 0.99, and a Brier score of .03. A risk score of >6 of 15 corresponded with a >10% probability of groin access complication (Table) .
Conclusions: Percutaneous ultrasound-guided access can be safely performed in almost all patients undergoing endovascular aortic procedures; however, access site failures still occur. Application of this risk score can help identify patients at high risk for complications after initial FA ultrasound-guided percutaneous access.
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Patient-Reported Outcomes in Patients With
Methods: We retrospectively analyzed all patients with ESRD presenting to the University of Utah Vascular Surgery clinic for dialysis access from January 2016 to February 2017. During this period, PROMIS PRO measures for depression and physical function were obtained at clinic visits. We evaluated PRO measures for depression and physical function among patients who received dialysis only via AVF versus those who required a TDC using mixed effects regression models and t tests for preprocedure and postprocedure comparisons
Results: A total of 174 patients with ESRD were identified, including 70 (40%) who received only AVF for dialysis and 104 (60%) who received a TDC for dialysis when AVF options did not exist or while waiting for AVF to mature. There was no significant difference in age, gender, 30-day readmission, or mortality between patients with ESRD receiving AVF versus TDC. Moreover, there was no significant difference in PRO depression (À1.72; 95% confidence interval [CI], À4.59 to 1.16; P ¼ .24) or physical function scores (0.61; 95% CI, À1.68 to 2.90; P ¼ .60) among patients using AVFs as compared with a TDC. Among patients with PRO assessment preprocedure and postprocedure, there was no difference in mean PRO score change over time for depression (AVF, 2.4 vs TDC, 1.9; P ¼ .85) and physical function (AVF, À0.7 vs TDC, À0.9; P ¼ .93).
Conclusions: Our study demonstrates that patients with ESRD using TDCs for hemodialysis did not suffer worse PRO measures for depression and physical function than patients dialyzed using AVF. These data suggest that selective use of TDC for dialysis does not adversely impact quality of life.
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Two-Stage Brachiobasilic Arteriovenous Fistula Creation Is Cost Effective
Claire L. Griffin, Benjamin S. Brooke, Rich Nelson. University of Utah, Salt Lake City, Utah
Objectives: There are two established strategies for creating brachiobasilic arteriovenous fistula (BB-AVF), a one-stage and two-stage approach. Although the comparative effectiveness of one-stage versus two-stage BB-AVF have been studied by multiple single center studies, a small randomized controlled trial and two meta-analyses, neither strategy has been shown to be superior with regards to durability, patency, or complications. This study was designed to evaluate the relative cost effectiveness of these different BB-AVF strategies.
Methods: A Markov decision analytic model was developed to estimate the costs, effects in quality-adjusted life-years (QALYs), and cost effectiveness of a one-stage and two-stage BB-AVF creation strategy. The model begins at the time of surgery for a new AVF and models a 5-year timespan using 1-month cycle lengths from the payer perspective. The baseline values, ranges, and costs were obtained from a systematic review of the literature and Centers for Medicare and Medicaid Services reimbursement by Current Procedural Terminology code. One-way and probabilistic sensitivity analyses were performed to evaluate parameter uncertainty. A 3% annual discount rate was applied and all costs were converted to 2016 U.S. dollars.
Results: In the base case, the two-stage approach was both more expensive ($4730 vs $4412) and more effective (3.74 vs 3.41 QALY) over the 5-year model. At a willingness to pay threshold of $50,000/QALY the two-stage approach was the dominant strategy with an incremental cost-effectiveness ratio of $948.36. A one-way sensitivity analysis identified the probability of the two-stage fistula failing to mature and the primary patency rates of both approaches as the inputs with the most impact on the model. In the probabilistic sensitivity analysis, the twostage approach was the most cost-effective strategy in 70% of the iterations.
Conclusions: Despite the additional resources associated with a twostage BB-AVF, this strategy is more cost effective than a one-stage approach.
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Outcomes of Peritoneal Dialysis Catheter Configurations and Pelvic Fixation
Methods: We conducted a retrospective analysis of patients undergoing PD catheter implantation between January 1, 2013, and December 31, 2016. All procedures were conducted laparoscopically at a single center in either a buried or unburied configuration. Patient data were extracted through chart review. Statistical analyses were conducted using Stata/SE 14.2 (StataCorp, College Station, Tex).
Results: Of the 165 patients, 93 (56%) were male, with a mean age of 58.5 6 14.6 years, and a mean body mass index of 30.2 6 6.6 kg/m 2 . Catheter characteristics and outcomes are summarized in the Table. Mean catheter survival was 536 6 401.3 days. The mean time to first revision for patients requiring revision was 362 6 459.9 days. Buried catheter configuration was found to be a statistically significant predictor of peritonitis at a mean of 481 6 341.3 days after catheter placement compared with the unburied configuration (P ¼ .008). The buried catheter was exteriorized at a mean of 100 6 107.8 days. Catheter removal was found to be significantly different between the buried and unburied groups (P ¼ .047). By logistic regression, a longer duration until exteriorization significantly correlated with the incidence of peritonitis, need for revision,
